General eCQM Information
|CMS Measure ID||CMS645v1|
Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.
|Initial Population||Male patients with a diagnosis of prostate cancer and an order for or who are actively undergoing ADT for a period greater than or equal to 12 months with an office visit during the measurement period|
Equals Initial Population
Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment
Patient refused recommendation for a bone density evaluation after the start of ADT therapy
|Measure Steward||Oregon Urology|
|Domain||Effective Clinical Care|
|Measure Scoring||Proportion measure|
|Measure Type||Process measure|
A higher score indicates better quality
In order to capture the practitioner's intent of androgen deprivation therapy (ADT) for a period of 12 months or greater, the custom HCPCS code of J1950,cont was added to the $ADT variable as Procedure, Order. Each EHR can define this custom code as intended therapy for 12 months or greater with the practitioner indicating this code at the start of the intended therapy.